|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.44 USD | -3.11% |
|
-1.49% | +0.65% |
| 11/02 | Exchange-Traded Funds, US Equities Mixed After Midday | MT |
| 11/02 | Invesco Bond Income Plus Prices Share Placement, Retail Offer | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 593.56Cr | 664.84Cr | 583.21Cr | 552.73Cr | 586.84Cr | |||||
Other Revenues, Total | 21Cr | 25Cr | 22Cr | 19Cr | 20Cr | |||||
Total Revenues | 614.56Cr | 689.45Cr | 604.89Cr | 571.64Cr | 606.7Cr | |||||
Cost of Goods Sold, Total | 426.53Cr | 458.66Cr | 415.11Cr | 425.7Cr | 436.65Cr | |||||
Gross Profit | 188.03Cr | 230.79Cr | 189.78Cr | 145.94Cr | 170.05Cr | |||||
Selling General & Admin Expenses, Total | 56Cr | 52Cr | 50Cr | 57Cr | 62Cr | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | 6.29Cr | 6.38Cr | 4.99Cr | 4.48Cr | |||||
Other Operating Expenses, Total | 56Cr | 59Cr | 56Cr | 62Cr | 67Cr | |||||
Operating Income | 131.62Cr | 172.23Cr | 133.89Cr | 84Cr | 103.22Cr | |||||
Interest Expense, Total | -32Cr | -26Cr | -31Cr | -7.05Cr | -5.8Cr | |||||
Interest And Investment Income | 32Cr | 30Cr | 40Cr | 27Cr | 20Cr | |||||
Net Interest Expenses | -10L | 4.95Cr | 9.03Cr | 20Cr | 14Cr | |||||
Income (Loss) On Equity Invest. | 7.27Cr | 21Cr | 11Cr | 7.13Cr | 4.3Cr | |||||
Currency Exchange Gains (Loss) | -23L | 33L | - | - | - | |||||
Other Non Operating Income (Expenses) | 4.09Cr | 5.74Cr | -12Cr | 5.3Cr | 4.77Cr | |||||
EBT, Excl. Unusual Items | 142.65Cr | 204.16Cr | 141.37Cr | 116.39Cr | 126.33Cr | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | -39Cr | 6.59Cr | -2.12Cr | -4.16Cr | - | |||||
Gain (Loss) On Sale Of Investments | 2.06Cr | 38Cr | -14Cr | -18Cr | -5.79Cr | |||||
Gain (Loss) On Sale Of Assets | - | - | - | 4.5Cr | - | |||||
Asset Writedown | - | - | - | -124.89Cr | - | |||||
Insurance Settlements | - | - | - | 2Cr | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | 1.53Cr | 1.01Cr | - | - | -20Cr | |||||
EBT, Incl. Unusual Items | 106.91Cr | 250.05Cr | 124.77Cr | -24Cr | 100.53Cr | |||||
Income Tax Expense | 26Cr | 53Cr | 32Cr | -6.97Cr | 25Cr | |||||
Earnings From Continuing Operations | 81Cr | 196.94Cr | 93Cr | -17Cr | 75Cr | |||||
Net Income to Company | 81Cr | 196.94Cr | 93Cr | -17Cr | 75Cr | |||||
Minority Interest | -4.59Cr | -34Cr | -48L | 7.13Cr | 2.24Cr | |||||
Net Income - (IS) | 76Cr | 162.98Cr | 92Cr | -9.69Cr | 77Cr | |||||
Preferred Dividend and Other Adjustments | 24Cr | 24Cr | 24Cr | 24Cr | 24Cr | |||||
Net Income to Common Incl Extra Items | 52Cr | 139.3Cr | 68Cr | -33Cr | 54Cr | |||||
Net Income to Common Excl. Extra Items | 52Cr | 139.3Cr | 68Cr | -33Cr | 54Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.14 | 3.01 | 1.49 | -0.73 | 1.18 | |||||
Basic EPS - Continuing Operations | 1.14 | 3.01 | 1.49 | -0.73 | 1.18 | |||||
Basic Weighted Average Shares Outstanding | 46Cr | 46Cr | 46Cr | 45Cr | 46Cr | |||||
Net EPS - Diluted | 1.13 | 2.99 | 1.49 | -0.73 | 1.18 | |||||
Diluted EPS - Continuing Operations | 1.13 | 2.99 | 1.49 | -0.73 | 1.18 | |||||
Diluted Weighted Average Shares Outstanding | 46Cr | 47Cr | 46Cr | 46Cr | 46Cr | |||||
Normalized Basic EPS | 1.84 | 2.02 | 1.92 | 1.76 | 1.78 | |||||
Normalized Diluted EPS | 1.83 | 2.01 | 1.91 | 1.75 | 1.77 | |||||
Dividend Per Share | 0.62 | 0.68 | 0.75 | 0.8 | 0.82 | |||||
Payout Ratio | 78.02 | 33.41 | 62.08 | -613.73 | 78.51 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 151.97Cr | 192.76Cr | 153.42Cr | 101.85Cr | 121.18Cr | |||||
EBITA | 137.87Cr | 178.52Cr | 140.27Cr | 89Cr | 107.7Cr | |||||
EBIT | 131.62Cr | 172.23Cr | 133.89Cr | 84Cr | 103.22Cr | |||||
EBITDAR | 163.26Cr | 203.26Cr | 163.45Cr | 111.75Cr | 131.15Cr | |||||
Total Revenues (As Reported) | 614.56Cr | 689.45Cr | 604.89Cr | 571.64Cr | 606.7Cr | |||||
Effective Tax Rate - (Ratio) | 24.47 | 21.24 | 25.82 | 29.3 | 25.16 | |||||
Current Domestic Taxes | 14Cr | 36Cr | 26Cr | 21Cr | 25Cr | |||||
Current Foreign Taxes | 3.55Cr | 9.52Cr | 96L | 3.28Cr | 3.85Cr | |||||
Total Current Taxes | 18Cr | 45Cr | 27Cr | 24Cr | 29Cr | |||||
Deferred Domestic Taxes | 6.28Cr | 9.49Cr | 3.41Cr | -28Cr | -2.13Cr | |||||
Deferred Foreign Taxes | 1.85Cr | -1.52Cr | 1.42Cr | -2.98Cr | -1.68Cr | |||||
Total Deferred Taxes | 8.13Cr | 7.97Cr | 4.83Cr | -31Cr | -3.81Cr | |||||
Normalized Net Income | 85Cr | 94Cr | 88Cr | 80Cr | 81Cr | |||||
Interest on Long-Term Debt | 13Cr | 9.47Cr | 8.52Cr | 7.05Cr | 5.8Cr | |||||
Non-Cash Pension Expense | -27L | -9L | -37L | 36L | 48L | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Marketing Expenses | 8.33Cr | 9.86Cr | 11Cr | 10Cr | 8.13Cr | |||||
Selling and Marketing Expenses | 8.33Cr | 9.86Cr | 11Cr | 10Cr | 8.13Cr | |||||
General and Administrative Expenses | 48Cr | 42Cr | 38Cr | 47Cr | 54Cr | |||||
Research And Development Expense From Footnotes | - | - | - | - | - | |||||
Net Rental Expense, Total | 11Cr | 10Cr | 10Cr | 9.9Cr | 9.97Cr | |||||
Imputed Operating Lease Interest Expense | 12Cr | 9.13Cr | 11Cr | 2.87Cr | 2.83Cr | |||||
Imputed Operating Lease Depreciation | -77.77L | 1.37Cr | -1.37Cr | 7.03Cr | 7.14Cr | |||||
Stock-Based Comp., COGS (Total) | 19Cr | 14Cr | 11Cr | 11Cr | 10Cr | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 19Cr | 14Cr | 11Cr | 11Cr | 10Cr |
- Stock Market
- Equities
- IVZ Stock
- Financials Invesco Ltd.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















